Clinical and Experimental Immunology 1992: Vol 90 Index

9 Pages·1992·1.7 MB·English

Author Index
ABRAHAM, E. & CHANG, Y.-H. Haemorrhage-induced alterations in BONARA, P. see CAPSONI, F.
function and cytokine production of T cells and T cell subpopula- BONNEFOY, J. see KARKAR, A.M.
tions, 497 BORCHERDING, W. see ARMSTRONG, N.
ACHARYA, S.K. see MISHRA, A. Bora, E.J. TER see SPRONK, P.E.
AGOSTINI, D. see CAPOBIANCHI, M.R. BoRGSTEIN, A. see TAYLOR, T.E.
AMBRUS, J. see Levy, E. Borne, A.E.G. Krk. VON DEM see VAN DE WikEL, B.A.
ANDREW, E. see CHu, C.Q. BREEDVELD, F.C. see OTTEN, H.G.
AnGus, H.B. see Extis, P.A. Breit, S.N. see THORNTON, S.C.
ANNENKOV, A.Y., STROKOV, A.G. & BARANOVA, F.S. Alterations in Brown, D.L. see KEOGAN, M.T.
mononuclear cell tumour necrosis factor-alpha (TNF-) response in BRUMMER-KORVENKONTIO, M. see WANGEL, A.G.
patients on long term cuprophane haemodialysis, 49 Buaains, A.G.S. see PEAKMAN, M.
AOTSUKA, S. see OKAWA-TAKATSUJI, M. BUTCHER, G.A. see TAYLOR, K.
ARAKAWA, M. see Ito, S.
ARMSTRONG, N., CIGEL, F., BORCHERDING, W., HONG, R. & Mat- Capore, J.L. see CoRDIER, G.
KOVSKA, V. Jn vitro preactivated human T cells engraft in SCID mice CAMPONESCHI, B. see PUGLIESE, O.
and migrate to murine lymphoid tissues, 476 Camps, J.A.J. see HALMA, C.
ASHANY, D., Hines, J.J., GHARAVI, A.E., MouRADIAN, J., DRAPPA, J. & CAPOBIANCHI, M.R., Fats, S., PAOLO, M.C. Di, AGosTIN1, D., PAOLUZ1I,
ELKON, K.B. MRL//pr—severe combined immunodeficiency mouse P., PALLONE, F. & DIANZANI, F. Absence of circulating interferon in
allografts produce autoantibodies, Acute graft-versus-host disease or patients with inflammatory bowel disease. Suggestion against an
a wasting syndrome depending on the source of cells, 466 autoimmune etiology, 85
CAPRILLI, F. see PUGLIESE, O.
BaBBs, C. see BLANN, A.D. CAPSONI, F., MINONZIO, F., ONGARI, A.M., CoLomso, G., RIZZARDI,
BacH, B.A. see LEVACHER, M. G.P., BONARA, P., D°ARMINIO-MONFOoRTE, A. & ZANUSSI, C.
BAEUERLE, P.A. see SCHRECK, R. Increased expression of IgG Fe receptor type I on neutrophils and
BaHR, G.M. see SCHRECK, R. monocytes from HIV-infected subjects, 175
Baker, D., O'NEILL, J.K., Davison, A.N. & Turk, J.L. Control of Carr, R.E. see TAYLOR, K.
immune-mediated disease of the central nervous system requires the CASHMAN, S.J. see KARKAR, A.M.
use ofa neuroactive agent; elucidation of the action of mitoxantrone, Castes, M. see SANTANA-BLANK, L.A.
124 CATTELL, V. see SEVER, R.
BAKIMER, R. see FISHMAN, P. CAVACINI, L.A., KENNEL, M., LALLY, E.V., POENER, M.R. & QUINN, A.
BAKKE, A.C. see BENNETT, R.M. Human immunoglobulin production in immunodeficient mice: en-
BANGA, J.P. see Ewins, D.L. hancement by immunosuppression of host and in vitro activation of
BARANOVA, F.S. see ANNENKOV, A.Y. human mononuclear cells, 135
BARNETT, P.S. see Ewins, D.L. CayotTa, A. see SCOTT-ALGARA, D.
BARRETT, K. see FOXWELL, B.M.J. Cuan, C.H.S. see LEUNG, J.C.K.
Base, B. see VAN De GRIEND, I.A. CHANG, Y.-H. see ABRAHAM, E.
BaTE, C.A.W. see TAYLOR, K. CHAPMAN, M. see Hussaln, L.A.
BATSFORD, S. see SCHMIEDEKE, T. CHEDID, L. see SCHRECK, R.
BAUMERT, E., WOLFF-VORBECK, G., SCHLESIER, M. & PETER, H.H. CuHeRSI, A. see PUGLIESE, O.
Immunophenotypical alterations in a subset of patients with common CHOUGNET, C., TALLET, S., RINGWALD, P. & DELORON, P. Kinetics of
variable immunodeficiency (CVID), 25 lymphocyte subsets from peripheral blood during a Plasmodium
BECKER, E.W. see LANG, P. faciparum malaria attack, 405
BeEM, E.M. see OTTEN, H.G. Cuu, C.Q., Fietp, M., ANDREW, E., HASKARD, D., FELDMAN, M. &
BELL, S.J.D., Cooper, D.A., Kemp, B.E., DoHERTY, R.R. & PENNY, R. MaINI, R.N. Detection of cytokines at the site of tuberculin-induced
Heterogeneous effects of exogenous II-2 on HIV-specific cell- delayed-type hypersensitivity in man, 522
mediated immunity (CMI), 6 Cuul, Y.L. see LEUNG, J.C.K.
BENNETT, R.M., CORNELL, K.A., MERRITT, M.J., BAKKE, A.C., CIGEL, F. see ARMSTRONG, N.
Mouricu, D. & HEFENEIDER, S.H. Idiotypic mimicry of a cell surface CILLARI, E. see VITALE, G.
DNA receptor: evidence for anti-DNA antibodies being a subset of CxiarK, K. see Lin, Y.
anti-anti-DNA receptor antibodies, 428 CLARK, M. see VAN DE GRIEND, I.A.
BERG, P.A. see LANG, P. CoFINER, C. see Loizou, S.
BERTOLLO, L. see PAGANELLI, R. CoGnf, M. see Lepuc, I.
Bevec, D. see SCHRECK, R. Cozzi, V. see PUGLIESE, O.
Bird, A.G. & WatTreT, K.C. CD8 T lymphocyte subset markers and Cour, D. see Watt, N.J.
HIV infection, 355 Co.ts, B.M. see Exits, P.A.
BisHop, S.A., WILLIAMS, N.A., GRUFFYDD-JongEs, T.J., HARBOUR, D.A. CoLomso, G. see CAPSONI, F.
& Stokes, C.R. An early defect in primary and secondary T cell Cook, T. see SEVER, R.
responses in asymptomatic cats during acute feline immunodeficiency CookE, A. see KNIGHT, B.
virus (FIV) infection, 491 Cooper, D.A. see BELL, S.J.D.
BJORKANDER, J. see LINDE, A. Corpikr, G., GUIGUEN, F., CADorE, J.L., COZON, G., JACQUIER, M.F. &
BLAKE, D.R. see STEVENS, T.R.J. Mornex, J.F. Characterization of the lymphocytic alveolitis in visna-
BLANK, M. see FISHMAN, P. maedi virus-induced interstitial lung disease of sheep, 18
BLANN, A.D., BaBBs, C. & NEUBERGER, J.M. Endothelial cell damage in CORNELL, K.A. see BENNETT, R.M.
primary biliary cirrhosis: influence of cholestasis and immunological CorRIGALL, V. see JOBANPUTRA, P.
mechanisms, 88 Cossarizza, A. see PAGANELLI, R.
545
546 Author Index
Cozon, G. see CorvigrR, G. GAMBINO, G. see VITALE, G.
Cozzi, E. see PAGANELLI, R. GarreD, P., THIEL, S., MADSEN, H.O., RYDER, L.P., JENSENIUS, J.C. &
CrarT, J. see KRATZ, A. SVEJGAARD, A. Gene frequency and partial protein characterization
Crowe, S.M. see NEATE, E.V. of an allelic variant of mannan binding protein associated with low
Cuve ier, C.A., De Wever, N., MIELANTS, H., DE Vos, M., Veys, E.M. serum concentrations, 517
& Roexs, H. Expression of T cell receptors «f and y6 in the ileal GEERARS, A. see VAN De GRIEND, I.A.
mucosa of patients with Crohn’s disease and with spondylarthro- GHARAVI, A.E. see ASHANY, D.
pathy, 275 GILLy, B. see GISSLINGER, H.
GISSLINGER, H., GILLy, B., WoLoszczuK, W., Mayr, W.R., HAVELEC,
D’ AGOSTINO, R. see V!ITALE, G. L., LinkescH, W. & WelsseL, M. Thyroid autoimmunity and
Dana, M.R. see HALMA, C. hypothyroidism during long-term treatment with recombinant inter-
Dana, M.R. see OTTEN, H.G. feron-alpha, 363
DaH_, H. see LINDE, A. GOLDRING, J.D. see TAYLOR, T.E.
D’Apice, A.J.F. see O°CONNELL, P.J. GOLDSCHMEDING, R. see VAN DE WiIEL, B.A.
D’ ARMINIO-MonrorTE, A. see CAPSONI, F. GreEN, A.J. see KEOGAN, M.T.
Das, A.C. see KARKAR, A.M. GREENHALGH, A.M. see NEATE, E.V.
Davison, A.N. see BAKER, D. Grup, R. see LINDE, A.
De CaROLis, C. see PERRICONE, R. GRUFFYDD-JONES, T.J. see BisHop, S.A.
De Gast, B. see VAN De GRIEND, I.A. GrRUnFELD, J.P. see HALBWACHS-MECARELLI, L.
DELORON, P. see CHOUGNET, C. GUERRA, E. see PAGANELLI, R.
DELVENTHAL, S., HENSEL, A., PETZOLDT, K. & Passt, R. Cellular GUIGUEN, F. see CoRDIER, G.
changes in the bronchoalveolar lavage (BAL) of pigs, following
immunization by the enteral or respiratory route, 223 Hack, C.E. see VAN De Wie, B.A.
De Rooy, H.H. see OTTEN, H.G. HALBWACHS-MECARELLI, L., NUSBAUM, P., NoéL, L.H., REUMAUx, D.,
De Vos, M. see CUVELIER, C.A. ERLINGER, S., GRUNFELD, J.P. & LesAvre, P. Antineutrophil cyto-
De Wever, N. see CUVELIER, C.A. plasmic antibodies (ANCA) directed against cathepsin G in ulcerative
DIANZANI, F. see CAPOBIANCHI, M.R. colitis, Crohn’s disease and primary sclerosing cholangitis, 79
Dieu, M. see VITALE, G. Hatma, C., Dana, M.R., Camps, J.A.J., Evers-SCHOUTEN, J.H.,
Dietz, A. see NUSSLEIN, H.G. PAuwELs, E.K.J. & VAN Es, L.A. Deficiency of complement compo-
DiGuiero, G. see SCOTT-ALGARA, D. nent c3 is associated with accelerated removal of soluble !**I-labelled
DsacpetTI, M. see FISHMAN, P. aggregates of IgG from the circulation, 394
DoLMAN, K.M. see VAN De WiEL, B.A. HAMBLIN, A.S. see SHAKOOR, Z.
Drappa, J. see ASHANY, D. HAMMARSTROM, L. see LINDE, A.
DuBerT, J.M. see ROSTOKER, G. HANAWA, H. see KODAMA, M.
Dukor, P. see SCHRECK, R. HANDSCHUMACHER, R.E. see KRATZ, A.
DurRGAPAL, H. see MISHRA, A. Harsour, D.A. see BisHop, S.A.
HARDING, M.W. see KRaTz, A.
EKDAHL, K. NILSSON see NILSSON, B. Hart, D.N.J. see Evvis, P.A.
ELKon, K.B. see ASHANY, D. HASKARD, D. see CHu, C.Q.
Exuis, P.A., Hart, D.N.J., CoLtts, B.M., Nimmo, J.C., MACDONALD, HAVELEC, L. see GISSLINGER, H.
J.E. & ANGus, H.B. Hodgkin’s cells express a novel pattern of HECHT, E.-M. see Hussain, L.A.
adhesion molecules, 117 HEFENEIDER, S.H. see BENNETT, R.M.
ELSAGHIER, A., PRANTERA, C., MORENO, C. & IVANy1, J. Antibodies to HENSEL, A. see DELVENTHAL, S.
Mycobacterium paratuberculosis-specific protein antigens in Crohn’s Horpy, N. see PRESSLER, T.
disease, 503 Hines, J.J. see ASHANY, D.
ERLINGER, S. see HALBWACHS-MECARELLI, L. Hino, S. see YOSHIOKA, K.
ESNAULT, V.L.M. see KEOGAN, M.T. Ho, R.T.H. see LEUNG, J.C.K.
ESPERSEN, F. see PRESSLER, T. Ho ters, V.M. see Levy, E.
EVANGELISTA, M. see PUGLIESE, O. Hotmskovy, U. see THIEL, S.
EVERS-SCHOUTEN, J.H. see HALMA, C. HomMEL, M. see TAYLor, T.E.
Ewins, D.L., BARNETT, P.S., RATANACHAIYAVONG, S., SHARROCK, C., Honpba, E. see YOSHIOKA, K.
LANCHBURY, J., McGREGOR, A.M. & BANGA, J.P. Antigen-specific T Hona, R. see ARMSTRONG, N.
cell recognition of affinity-purified and recombinant thyroid peroxi- HOOGENDOORN, L.I. see OTTEN, H.G.
dase in autoimmune thyroid disease, 93 HULSTAERT, F. see LEVACHER, M.
Hussain, L.A., KELLY, C.G., FELLoweEs, R., HECHT, E.-M., WILSON, J.,
FAGIOLO, U. see PAGANELLI, R. CHAPMAN, M. & LEHNER, T. Expression and gene transcript of Fe
Fats, S. see CAPOBIANCHI, M.R. receptors for IgG, HLA class II antigens and Langerhans cells in
Fe1, P. CoRDIALI see PUGLIESE, O. human cervico-vaginal epithelium, 530
FELDMAN, M. see Cuu, C.Q. HUTCHINGS, P. see KNIGHT, B.
FELDMANN, M. see FOxWELL, B.M.J. Hvup, L. see THIEL, S.
FELLOWES, R. see Hussain, L.A.
FIELD, M. see Cuu, C.Q. IBRAHIM, M.A. see KNIGHT, B.
Fitipovicn, A.H. see MONAFO, W.J. ImuRA, H. see MURAKAMI, M.
FISHMAN, P., BAKIMER, R., BLANK, M., SREDNI, D., DJALDETTI, M. & ISENBERG, D.A. see KNIGHT, B.
SHOENFELD, Y. The putative role of cytokines in the induction of Ito, S., UENo, M., Nisui, S., ARAKAWA, M. & Fustwara, M.
primary anti-phospholipid syndrome in mice, 266 Suppression of spontaneous murine lupus by inducing graft-versus-
Fisicaro, N. see O'CONNELL, P.J. host reaction with CD8* cells, 260
FOMSGAARD, A. see PRESSLER, T. IVANYI, J. see ELSAGHIER, A.
FONTANA, E. see PERRICONE, R. Iwal, K. see MURAKAMI, M.
ForsyTHE, J.L.R. see Lin, Y. IWANAGA, T. see KAWACHI, H.
FOxWELL, B.M.J., BARRETT, K. & FELDMANN, M. Cytokine receptors:
structure and signal transduction, 161 JACQUIER, M.F. see CorpieER, G.
FRANCESCHI, C. see PAGANELLI, R. JARSTRAND, C. see RASOOL, O.
Fusiwara, M. see Ito, S. JENSENIUS, J.C. see GARRED, P.
Author Index
JENSENIUS, J.C. see THIEL, S. LiMBuRG, P.C. see SPRONK, P.E.
JOBANPUTRA, P., CORRIGALL, V., KINGSLEY, G. & PANAy1, G. Cellular Lin, M. see RUMORE, P
responses to human chondrocytes: absence of allogeneic responses in Lin, Y., Kirsy, J.A., CLARK, K., SHENTON, B.K., FORSYTHE, J.L.R.,
the presence of HLA-DR and ICAM-1, 336 Proup, G. & TAYLor, R.M.R. Renal allograft rejection: induction
and function of adhesion molecules on cultured epithelial cells, 111
LINDE, A., SODERSTROM, R., SMITH, C.1. EDVARD, SALLBERG, M., DAHL,
KAHL, L. see Levy, E.
H., Gruss, R., BJGRKANDER, J. & HAMMARSTROM, L. Herpesvirus
KALDEN, J.R. see NUSSLEIN, H.G.
serology, aberrant specific immunoglobulin G2 and G3 subclass
KALLENBERG, C.G.M. see SPRONK, P.E.
patterns and Gm allotypes in individuals with low levels of lgG3, 199
KARKAR, A.M., KOSHINO, Y., CASHMAN, S.J., DASH, A.C., BONNEFOY,
LINKESCH, W. see GISSLINGER, H.
J., MEAGER, A. & Rees, A.J. Passive immunization against tumour
Lockwoob, C.M. see KEOGAN, M.T.
necrosis factor-alpha (TNF-«) and IL-1 protects from LPS enhanc-
ing glomerular injury in nephrotoxic nephritis in rats, 312 Loizou, S., COFINER, C., WEETMAN, A.P. & WALPoRT, M.J. Immuno-
Katz, D.R. see KNIGHT, B. globulin class and IgG subclass distribution of anticardiolipin
antibodies in patients with systemic lupus erythematosus and asso-
KAWACHI, H., IWANAGA, T., ToyaBE, S., Orre, T. & SHimizu, F.
ciated disorders, 434
Mesangial sclerotic change with persistent proteinuria in rats after
LorGaT, F., KERAAN, M.M. & Ress, S.R. Cellular immunity in
two consecutive injections of monoclonal antibody 1-22-3, 129
tuberculous pleural effusions: evidence of spontaneous lymphocyte
KELLY, C.G. see Hussain, L.A.
proliferation and antigen-specific accelerated responses to purified
Kemp, B.E. see BELL, S.J.D.
KENNEL, M. see CAVACINI, L.A. protein derivative (PPD), 215
LUNARDI, C., MARGUERIE, C. & So, A.K. An altered repertoire of T cell
KEOGAN, M.T., ESNAULT, V.L.M., GREEN, A.J., Lockwoop, C.M. &
Brown, D.L. Activation of normal neutrophils by anti-neutrophil receptor V gene expression by rheumatoid synovial fluid T lympho-
cytoplasm antibodies, 228 cytes, 403
KERAAN, M.M. see LorGart, F.
KINGSLEY, G. see JOBANPUTRA, P. MaarL, M.G.J. VAN DER see OTTEN, H.G.
Kirby, J.A. see Lin, Y. MACDONALD, J.E. see ELis, P.A.
MAaAcInTYyrE, N. see WATT, N.J.
KITAMURA, H. see SHINGU, M.
KLEIN, R. see LANG, P. MACKWORTH-YOUNG, C.G. see KRATZ, A.
KLockars, M. & SAVOLAINEN, H. Tumour necrosis factor enhances the Mansen, H.O. see GARRED, P.
MAIN, R.N. see CHu, C.Q.
asbestos-induced production of reactive oxygen metabolites by
human polymorphonuclear leucocytes (PMN), 68 Mak, S. see YOSHIOKA, K.
KNIGHT, B., KATZ, D.R., ISENBERG, D.A., IBRAHIM, M.A., PAGE, S. LE, MALKOVSKA, V. see ARMSTRONG, N.
MALTA, R. see VITALE, G.
HUTCHINGS, P., SCHWARTZ, R.S. & Cooke, A. Induction of adjuvant
MANIVEL, V. see MISHRA, A.
arthritis in mice, 459
MANSUETO, S. see VITALE, G.
Kocn, C. see PRESSLER, T.
MARGUERIE, C. see LUNARDI, C.
Kopama, M., ZHANG, S., HANAWA, H. & SHisaTta, A. Immunohistoche-
Massimo, A.M. Di see PUGLIESE, O.
mical characterization of infiltrating mononuclear cells in the rat
MATHER, A. see MONAFO, W.J.
heart with experimental autoimmune giant cell myocarditis, 330
MATSUSHIMA, K. see THOMPSON, H.L.
KOSHINO, Y. see KARKAR, A.M.
Mayr, W.R. see GISSLINGER, H.
KRATZ, A., HARDING, M.W., CraFT, J., MACKWORTH-YOUNG, C.G. &
MCCONNELL, I. see WaTT, N.J.
HANDSCHUMACHER, R.E. Autoantibodies against cyclophilin in sys-
McpDonaLp, T.L. see SMITH, J.W.
temic lupus erythematosus and Lyme disease, 422
McGreGor, A.M. see Ewins, D.L.
KUMAGAI, S. see MURAKAMI, M.
McKENZIE, A. see O°CONNELL, P.J.
McPueE, D.A. see NEATE, E.V.
LAGRUE, G. see ROSTOKER, G. MeEaGer, A. see KARKAR, A.M.
Lal, C. see RuMoRE, P. MEILLET, D. see ROSTOKER, G.
Lal, C.K.W. see LEUNG, J.C.K. Merritt, M.J. see BENNETT, R.M.
Lal, K.N. see LEUNG, J.C.K. MIELANTS, H. see CUVELIER, C.A.
LALANI, S. see TEODORCZYK-INJEYAN, J.A. MILLS, G.B. see TEODORCZYK-INJEYAN, J.A.
LALLY, E.V. see CAVACINI, L.A. MINONZIO, F. see CAPSONI, F.
LANCHBURY, J. see Ewins, D.L. Misura, A., DURGAPAL, H., MANIVEL, V., ACHARYA, S.K., RAO, K.V.S.
LANG, P., KLEIN, R., BECKER, E.W. & BERG, P.A. Distribution of the & Panpba, S.K. Immune response to hepatitis B virus surface antigen
PBC-specific- (M2) and the naturally-occurring mitochondrial anti- peptides during HBV infection, 194
gen- (NOMAg) systems in plants, 509 MriyasaTo, H. see YOSHIOKA, K.
LANG, P. see ROSTOKER, G. Mocciaro, C. see VITALE, G.
LauRSEN, S.B. see THIEL, S. Mo ina, H. see Levy, E.
Layton, D.M. see PEAKMAN, M. Mo tyneux, M.E. see TAYLor, T.E.
Lepuc, I., PREUD’ HOMME, J.-L. & CoGng, M. Structure and expression Monaro, W.J., PoLMAR, S.H., Neuporr, S., MATHER, A. & FILIPOVICH,
of the mb-/ transcript in human lymphoid cells, 141 A.H. A hereditary immunodeficiency characterized by CD8* T
LEHNER, T. see HUSSAIN, L.A. lymphocyte deficiency and impaired lymphocyte activation, 390
LERNER, R. see PALMBLAD, J.E.W. Monteriort!, D.C., ZHou, J. & SHAFF, D.I. CD4-independent binding of
LESAVRE, P. see HALBWACHS-MECARELLI, L. HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of
LEUNG, J.C.K., Lat, C.K.W., Cuul, Y.L., Ho, R.T.H., CHAN, C.H.S. & complement and antibody, 383
Lai, K.N. Characterization of cytokine gene expression in CD4* and Mont, D. see PAGANELLI, R.
CD8* T cells after activation with phorbol myristate acetate and Moreno, C. see ELSAGHIER, A.
phytohaemagglutinin, 147 Mornex, J.F. see CorDIER, G.
LEVACHER, M., HULSTAERT, F., TALLET, S., ULLERY, S., POCIDALO, J.J. Mourapian, J. see ASHANY, D.
& Bacu, B.A. The significance of activation markers on CD8 Mouricu, D. see BENNETT, R.M.
lymphocytes in human immunodeficiency syndrome: staging and MULLER, S. see SCHMIEDEKE, T.
prognostic value, 376 MurRAKAMI, M., KumaGal, S., SuGiTa, M., Iwai, K. & IMurRA, H. Jn
Levy, E., AMBRus, J., KAHL, L., MOLINA, H., TUNG, K. & HOLERS, V.M. vitro induction of IgG anti-DNA antibody from high density B cells of
T lymphocyte expression of complement receptor 2 (CR2/CD21): a systemic lupus erythematosus patients by an HLA DR-restricted T
role in adhesive cell-cell interactions and dysregulation in a patient cell clone, 245
with systemic lupus erythematosus (SLE), 235 MUuRALIDHAR, B. see RUMORE, P.
548 Author Index
NeaATE, E.V., GREENHALGH, A.M., McpuHee, D.A. & Crowe, S.M. PociDaALo, J.J. see LEVACHER, M.
Bacterial lipopolysaccharide mediates the loss of CD4 from the PoLMaAR, S.H. see MONAFO, W.J.
surface of purified peripheral blood monocytes, 539 PRANTERA, C. see ELSAGHIER, A.
NEUBERGER, J.M. see BLANN, A.D. PRESSLER, T., PANDEY, J.P., ESPERSEN, F., PEDERSEN, S.S., FOMSGAARD,
Neuporr, S. see MONAFO, W.J. A., Kocu, C. & Hoiwy, N. Immunoglobulin allotypes and IgG
NICOLAIDES, K.H. see PEAKMAN, M. subclass antibody response to Pseudomonas aeruginosa antigens in
Nitsson, B., EKDAHL, K. NILSSON, SJGHOLM, A., Nitsson, U.R. & chronically infected cystic fibrosis patients, 209
SturFectT, G. Detection and characterization of immunoconglutinins Preup’ Homme, J.-L. see Lepuc, I.
in patients with systemic lupus erythematosus (SLE): serial analysis in Proub, G. see Lin, Y.
relation to disease course, 251 PuciLLo, L.P. see PAGANELLI, R.
NILsson, U.R. see NILsson, B. PuGLigsE, O., ViorA, M., CAMPONESCHI, B., FEI, P. CORDIALI, CAPRILLI,
Nimmo, J.C. see Evuis, P.A F., CHersi, A., EVANGELISTA, M., Massimo, A.M. Di & Couizzi, V. A
Nisui, S. see Ivo, S. gp|20 HIV peptide with high similarity to HLA class II f chains
NISHIMUKAI, H. see SHINGU, M. enhances PPD-specific and autoreactive T cell activation, 170
NNALUE, N.A. see RASOOL, O.
NosunaGa, M. see SHINGU, M. Quinn, A. see CAVACINI, L.A.
Noccio.i, G. see PERRICONE, R QuINTI, I. see PAGANELLI, R.
Noé., L.H. see HALBWACHS-MECARELLI, L.
Nonaka, S. see SHINGU, M.
NussauM, P. see HALBWACHS-MECARELLI, L. RapeKE, H.H., SCHWINZER, B. & RESCH, K. Activated T-lymphocytes
induce growth inhibition and prostaglandin E> release from syngeneic
NUssLeIn, H.G., TRAG, T., WINTER, M., Dietz, A. & KALDEN, J.R. The
role of T cells and the effect of hydrocortisone on interleukin-4- glomerular mesangial cells, 483
induced IgE synthesis by non-T cells, 286 Rampton, D.S. see STEVENS, T.R.J.
Rao, K.V.S. see MISHRA, A.
O’CONNELL, P.J., McKENZIE, A., FISICARO, N., ROCKMAN, S.P., PEARSE, RasooL, O., NNALUE, N.A. & JARSTRAND, C. The role of O-antigen
M.J. & D’Apice, A.J.F. Endoglin: a 180-kD endothelial cell and polysaccharide in the activation of neutrophils by lipopolysacchar-
macrophage restricted differentiation molecule, 154 ides of Salmonella species, 63
Orte, T. see KAWACHI, H. RATANACHAIYAVONG, S. see Ewins, D.L.
OKAWa-TAKATSUJI, M., AOTSUKA, S., UwaToxko, S., SumiyA, M. & Rees, A.J. see KARKAR, A.M.
YOKOHARI, R. The B cell repertoire in patients with systemic REINA, G. see VITALE, G.
autoimmune diseases: analysis of Epstein—Barr virus (EBV)-induc- Rescu, K. see RADEKE, H.H.
ible circulating precursors that produce autoantibodies against Ress, S.R. see LorGAT, F.
nuclear ribonucleoprotein (nRNP), 415 REUMAUX, D. see HALBWACHS-MECARELLI, L.
O'NEILL, J.K. see BAKER, D RINGWALD, P. see CHOUGNET, C.
OnGaRI, A.M. see CAPSONI, F Rizzarpi, G.P. see CAPSONI, F.
OrRTOLANI, C. see PAGANELLI, R. Rossins, J.M. see THORNTON, S.C.
Otten, H.G., DAHA, M.R., MAARL, M.G.J. VAN DER, HOOGENDOORN, ROCKMAN, S.P. see O'CONNELL, P.J.
L.I., BEEM, E.M., De Rooy, H.H. & BREEDVELD, F.C. IgA rheuma- Roe.s, H. see CUVELIER, C.A.
toid factor in mucosal fluids and serum of patients with rheumatoid Rosas, M.E. see SANTANA-BLANK, L.A.
arthritis: immunological aspects and clinical significance, 256 RosToKER, G., TERZIDIS, H., PETIT-PHAR, M., MEILLET, D., LANG, P.,
DuBertT, J.M., LAGRUE, G. & WEIL, B. Secretory IgA are elevated in
both saliva and serum of patients with various types of primary
PassT, R. see DELVENTHAL, S.
PAGANELLI, R., QUINTI, I., FAGIOLO, U., CossariIzZA, A., ORTOLANI, C., glomerulonephritis, 305
Rumore, P., MURALIDHAR, B., Lin, M., Lat, C. & STEINMAN, C.R.
GuerrRA, E., SANSONI, P., PucILLO, L.P., SCALA, E., Cozzi, E.,
BERTOLLO, L., Monti, D. & FRANCESCHI, C. Changes in circulating B Haemodialysis as a model for studying endogenous plasma DNA:
oligonucleosome-like structure and clearance, 56
cells and immunoglobulin classes and subclasses in a healthy aged
population, 351 Ryper, L.P. see GARRED, P.
PaGe, S. LE see KNIGHT, B.
PALLONE, F. see CAPOBIANCHI, M.R. SALLBERG, M. see LINDE, A.
PALMBLAD, J.E.W. & LERNER, R. Leukotriene B4-induced hyperadhesi- SANSONI, P. see PAGANELLI, R.
veness of endothelial cells for neutrophils: relation to CD54, 300 SANTANA-BLANK, L.A., Castes, M., Rosas, M.E., VARGAS, F. & ScoTT-
PAaNayl, G. see JOBANPUTRA, P. ALGaRA, D. Evaluation of serum levels of tumour necrosis factor-
PANDA, S.K. see MISHRA, A. alpha (TNF-a) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and
PANDEY, J.P. see PRESSLER, T. natural killer (NK) populations during infrared pulsed laser device
PANERAI, A.E. see PERRICONE, R. (IPLD) treatment, 43
PaoLo, M.C. Di see CAPOBIANCHI, M.R. SaRGAN, D. see Watt, N.J.
PAOLUZI, P. see CAPOBIANCHI, M.R. SAVOLAINEN, H. see KLocKaRsS, M.
PaseTTO, N. see PERRICONE, R. SCALA, E. see PAGANELLI, R.
PAUWELS, E.K.J. see HALMA, C. SCHLESIER, M. see BAUMERT, E.
PEAKMAN, M., BuGGiNs, A.G.S., NicoLaipes, K.H., Layton, D.M. & SCHMIEDEKE, T., STOECKL, F., MULLER, S., SUGISAKI, Y., BATSFORD, S.,
VeRGANI, D. Analysis of lymphocyte phenotypes in cord blood from Wortas, R. & VoGt, A. Glomerular immune deposits in murine lupus
early gestation fetuses, 345 models may contain histones, 453
PEARSE, M.J. see O°CONNELL, P.J. ScHRECK, R., Bevec, D., DuKor, P., BAEUERLE, P.A., CHEDID, L. &
PEDERSEN, S.S. see PRESSLER, T. Baur, G.M. Selection of a muramyl peptide based on its lack of
PENNY, R. see THORNTON, S.C. activation of nuclear factor-xB as a potential adjuvant for AIDS
PENNY, R. see BELL, S.J.D. vaccines, 188
PERRICONE, R., PASETTO, N., DE CAROLIS, C., VAQUERO, E., NOCCIOLI, SCHWARTZ, R.S. see KNIGHT, B.
G., PANERAI, A.E. & FONTANA, E. Cystic ovaries in women affected SCHWINZER, B. see RADEKE, H.H.
with hereditary angioedema, 401 ScoTT-ALGARA, D. see SANTANA-BLANK, L.A.
Peter, H.H. see BAUMERT, E. ScoTt-ALGaRA, D., VUILLIER, F., CAyoTA, A. & DIGHIERO, G. Natural
PETERS, W.J. see TEODORCZYK-INJEYAN, J.A. killer (NK) cell activity during HIV infection: a decrease in NK
PETIT-PHAR, M. see ROSTOKER, G. activity is observed at the clonal level and is not restored after in vitro
PETZOLDT, K. see DELVENTHAL, S. long-term culture of NK cells, 181
PLAYFAIR, J.H.L. see TAYLOR, K. SeEveR, R., Cook, T. & CATTELL, V. Urinary excretion of nitrite and
Author Index 549
nitrate in experimental glomerulonephritis reflects systemic immune growth factors in connective tissue disease associated interstitial lung
activation and not glomerular synthesis, 326 disease, 447
Suarr, D.I. see MONTEFIORI, D.C. Tomo-OKa, K. see SHINGU, M.
SHAKOOR, Z. & HAMBLIN, A.S. Increased CD11/CD18 expression on Toyase, S. see KAWACHI, H.
peripheral blood leucocytes of patients with sarcoidosis, 99 TRAG, T. see NUSSLEIN, H.G.
SHARROCK, C. see Ewins, D.L. TUNG, K. see Levy, E.
SHENTON, B.K. see Lin, Y. Turk, J.L. see BAKER, D.
SHIBATA, A. see KODAMA, M.
SHIMIZU, F. see KAWACHI, H. UENO, M. see ITO, S.
SHINGU, M., NoONAKA, S., NISHIMUKAI, H., NOBUNAGA, M., KITAMURA, ULLERY, S. see LEVACHER, M.
H. & Tomo-OKa, K. Activation of complement in normal serum by UwatToko, S. see OKAWA-TAKATSUII, M.
hydrogen peroxide and hydrogen peroxide-related oxygen radicals
produced by activated neutrophils, 72 VAHERI, A. see WANGEL, A.G.
SHOENFELD, Y. see FISHMAN, P. VAN DE GRIEND, I.A. HAAGEN R., CLARK, M., GEERARS, A., BASE, B. &
SJGHOLM, A. see NILSSON, B. De Gast, B. Killing of human leukaemia/lymphoma B cells by
SmiTH, C.I. EDVARD see LINDE, A. activated cytotoxic T lymphocytes in the presence of a bispecific
Situ, J.W. & MCDONALD, T.L. Production of serum amyloid A and C- monoclonal antibody («CD3/«CD19), 368
reactive protein by HepG?2 cells stimulated with combinations of VaN Der MEER-GERRITSEN, C.H. see VAN DE WIEL, B.A.
cytokines or monocyte conditioned media: the effects of predniso- VAN De WIEL, B.A., DoLMAN, K.M., VAN DER MEER-GERRITSEN, C.H..,
lone, 293 Hack, C.E., Borne, A.E.G. Kr. Von Dem & GOLDSCHMEDING, R.
So, A.K. see LUNARDI, C. Interference of Wegener’s granulomatosis autoantibodies with neu-
SODERSTROM, R. see LINDE, A. trophil Proteinase 3 activity, 409
SpaRKES, B.G. see TEODORCZYK-INJEYAN, J.A. VaN Es, L.A. see HALMA, C.
SPRONK, P.E., BorG, E.J. TER, LimBurG, P.C. & KALLENBERG, C.G.M. VAQUERO, E. see PERRICONE, R.
Plasma concentration of IL-6 in systemic lupus erythematosus; an VaRGAS, F. see SANTANA-BLANK, L.A.
indicator of disease activity?, 106 VERGANI, D. see PEAKMAN, M.
SREDNI, D. see FISHMAN, P. Veys, E.M. see CUVELIER, C.A.
STEINMAN, C.R. see RUMORE, P. Viora, M. see PUGLIESE, O.
STEVENS, T.R.J.. Winrow, V.R., BLAKE, D.R. & Rampton, D.S. ViITALE, G., REINA, G., MANSUETO, S., MALTA, R., GAMBINO, G.,
Circulating antibodies to heat-shock protein 60 in Crohn's disease Mocciaro, C., D’aGostino, R., Dieti, M. & CILLARI, E. The
and ulcerative colitis, 271 significance of serum soluble IL-2 receptor as a marker for active
STOECKL, F. see SCHMIEDEKE, T. visceral leishmaniasis in Sicilian patients, 219
Stokes, C.R. see BisHop, S.A. VocT, A. see SCHMIEDEKE, T.
Strokov, A.G. see ANNENKOV, A.Y. VuILuigR, F. see SCOTT-ALGARA, D.
STurRFELT, G. see NILSSON, B.
SUGISAKI, Y. see SCHMIEDEKE, T. Wa port, M.J. see Loizou, S.
Suaita, M. see MURAKAMI, M. WANGEL, A.G., TEMONEN, M., BRUMMER-KORVENKONTIO, M. &
Sumiya, M. see OKAWA-TAKATSUIJI, M. VAHERI, A. Anti-endothelial cell antibodies in nephropathia epide-
SVEJGAARD, A. see GARRED, P. mica and other viral diseases, 13
WaTRET, K.C. see BirD, A.G.
TAKEMURA, T. see YOSHIOKA, K. Watt, N.J., MACINTYRE, N., CoLuiz, D., SARGAN, D. & MCCONNELL, I.
TALLET, S. see CHOUGNET, C. Phenotypic analysis of lymphocyte populations in the lungs and
TALLET, S. see LEVACHER, M. regional lymphoid tissue of sheep naturally infected with maedi visna
TAVERNE, J. see TAYLOR, K. virus, 204
TayYLor, K., BATE, C.A.W., CARR, R.E., BUTCHER, G.A., TAVERNE, J. & WEETMAN, A.P. see Loizou, S.
PLayYFAiR, J.H.L. Phospholipid-containing toxic malaria antigens WEIL, B. see ROSTOKER, G.
induce hypoglycaemia, | WEISSEL, M. see GISSLINGER, H.
TAYLOR, R.M.R. see Lin, Y. WILLIAMS, N.A. see BisHop, S.A.
TAYLOR, T.E., MOLYNEUX, M.E., WiRIMA, J.J., BORGSTEIN, A., GOLDR- WILson, J. see Hussain, L.A.
ING, J.D. & Homme, M. Intravenous immunoglobulin in the Winrow, V.R. see STEVENS, T.R.J.
treatment of paediatric cerebral malaria, 357 WinTER, M. see NUSSLEIN, H.G.
TEMONEN, M. see WANGEL, A.G. WiriMA, J.J. see TAYLOR, T.E.
TEODORCZYK-INJEYAN, J.A., SPARKES, B.G., LALANI, S., PETERS, W.J. & Worras, R. see SCHMIEDEKE, T.
Mits, G.B. IL-2 regulation of soluble IL-2 receptor levels following WOLFF-VoRBECK, G. see BAUMERT, E.
thermal injury, 36 WoLoszczuK, W. see GISSLINGER, H.
Terzipis, H. see ROSTOKER, G.
TuiEL, S., Hotmskov, U., Hvup, L., LAURSEN, S.B. & JENSENIUS, J.C. YOKOHARI, R. see OKAWA-TAKATSUIJI, M.
The concentration of the C-type lectin, mannan-binding protein, in YosuHioKa, K., Hino, S., TAKEMURA, T., MryasaTo, H., Honpa, E. &
human plasma increases during an acute phase response, 31 Mak, S. Isolation and characterization of the tubular basement
THIEL, S. see GARRED, P. membrane antigen associated with human tubulo-interstitial nephri-
THompson, H.L. & MatsusHiMA, K. Human polymorphonuclear tis, 319
leucocytes stimulated by tumour necrosis factor-alpha show
increased adherence to extracellular matrix proteins which is ZaNussI, C. see CAPSONI, F.
mediated via the CD11b/18 complex, 280 ZHANG, S. see KODAMA, M.
THORNTON, S.C., Roppins, J.M., PENNY, R. & Breit, S.N. Fibroblast Zuovu, J. see MONTEFIORI, D.C.
Subject Index
{ctinobacillus ( Haemophilus ) pleuropneumoniae, 22 CD8* cells, 260, 497
activated T cells, 368 CR2, 235
activated human T cells, 476 cancer, 43
activation, 376 cardiac myosin, 330
acute and chronic hepatitis, 194 cDNA, 141
acute phase proteins, 106 cell adhesion, 235, 300
acute phase reactant, 31 cellular immunity, 215
adhesion, I11, 280 cellular immunology, 336
adhesion molecules, 25, 117 centenarians, 351
adjuvant arthritis, 459 central nervous system, 124
adjuvants, 188 cerebral malaria, 357
ageing, 351 cervico-vaginal mucosa, 530
AIDS, 175, 188, 376, 491 chemiluminescence, 228
allograft, 111 cholestasis, 88
alpha 2-macroglobulin, 312 chondrocytes, 336
alpha;-antitrypsin, 409 cloned NK cells, 181
alveolar lymphocytes, 18 common variable immunodeficiency, 25
alveolar macrophages, 447 complement, 517
amino acid sequence, 319 complement activation, 72.25]
ANCA, 79, 228 complement deficiency, 394
anti-DNA antibodies, 428 complement receptor type | (CRI, CD35), 394
anti-DNA antibody, 245 connective tissue diseases, 447
anti-M2, 509 corticosteroids, 293
anti-RNP antibodies, 415 Crohn’s disease, 9, 271, 275, 503
anti-cardiolipin antibodies, 266 cuprophane, 49
inti-cathepsin G antibodies, 79 cyclophilin, 422
anti-endothelial cell antibodies, 13 cystic fibrosis, 209
inti-idiotypic anti-DNA, 428 cystic ovaries, 401
anti-phospholipid syndrome, 266 cytofluorometry, 43
inti-receptor antibodies, 428 cytokine, I11, 161
anti-tubular basement membrane antibody, 319 cytokine gene, 147
antibodies, 428, 503 cytokines 43, 106. 266, 293, 497
antibody reactivity, 194 cytotoxicity, 368
anticardiolipin antibodies, 434
antigen, 260 DNA receptor, 428
asbestos, 68 deficiency, 517
autoantibodies, 266, 459, 466 dendritic cells, 117
iutoantibody, 422 differentiation marker, 154
autoantibody production, 245
autoimmune myocarditis, 330 endoglin, 154
1utoimmunity, 56, 85, 266, 483 endothelial cell, 154
autoreactive T cell, 245 endothelial cells, 300
autoreactivity, 170 epithelial cell, 111
Epstein-Barr virus, 199, 415
experimental allergic encephalomyelitis, 124
B cell specific expression, 141
B lymphocytes, 351
falciparum, 405
B-| cells, 345 Fe receptors, 175
beta-endorphin, 401
FeyR, 530
bilirubin, 88
feline immunodeficiency virus, 491
bispecific monoclonal antibodies, 368
bronchoalveolar lavage, 92 223 fetal blood, 345
fetal lymphocytes, 345
burn immunosuppression, 36
fibroblast growth factors, 447
C-ANCA, 409 fibronectin, 447
C-reactive protein, 31, 293 GM-CSF, 266
C3, 394 riida nt cell, 330
CDI1/CDI189,9 glomerular mesangial cells, 483
CD38, 376 ggyl l omerulonephritis, 326, 483
CD4, 539 Gm allotypes, 199
CD4 cells, 376 Gm types, 209
CD4* T cells, 147
graft-versus-host disease, 466
CD4* cells, 497 graft-versus-host reaction, 260
CD45R isoforms, 345 Graves’ disease, 93
CD8& cells, 376
CD8* T cells, 147 haematopoietic growth factor, 161
CD8* T lymphocyte, 390 haemodialysis, 49
Subject Index
haemorrhage, 497 leukotrienes, 300
Hashimoto's thyroiditis, 93 LFA-3, I11
heat-shock protein, 271 limiting dilution analysis, 415
HepG2, 293 ipopolysaccharide, 312, 539
hepatitis B virus, 194 lipopolysaccharides, 63
hereditary angioedema, 401 ongitudinal, 106
HHV-6, 199 ung, 204
high-density B cell, 245 Lyme disease, 422
histone peptide antibodies, 453 lymphocyte, 204
histones, 453 ymphocyte activation, 390
HIV, 6, 170, 376, 530 ymphocyte development, 390
HIV infection, 181 ymphocyte proliferation, 215
HIV receptors, 383 ymphocyte subsets, 376, 405
HLA class II, 170, 530 ymphocyte surface molecules, 25
HLA-DR, 376 ymphokine, 161
Hodgkin’s cells, 117 ymphokines, 266
human immunoglobulin, 135 lymphoproliferation, 6
human mb-/, 141 ysozyme release, 63
human ovarian follicular fluid
hydrocortisone, 286 macrophage, 129, 154
hydrogen peroxide, 7 , malaria, 1, 405
hypochlorite, 72 malignant B cells, 368
hypoglycaemia, | mannan binding protein, 31, 517
hypothyroidism, 363 mannose-binding protein, 31
membrane immunoglobulin, 141
ICAM-1, I11 membranous nephropathy, 305
idiopathic nephrotic syndrome, 305 mesangial sclerosis, 129
idiotypic mimicry, 428 MHC antigens, 336
IFN-x, 363 MHC class I, 260
IFN-}, 483 mitochondrial antigens, 509
Ig A. 256 mitoxantrone, 124
IgA HSP-60 antibodies, 271 MoAb, 129
IgA mesangial glomerulonephritis, monoclonal antibody, 154
IgA monomer / polymer ratio, 305 monocyte, 49, 539
IgE synthesis, 286 monocytes, 175
IgG, 251 MRL /pr mouse, 466
IgG aggregates, 394 mRNA, 147
IgG subclass, 434 mucosal fluids, 256
IgG subclasses, 199, 209, 351 multifollicular ovaries, 401
IgG3 deficiency, 199 multiple sclerosis, 124
IgM, 251 muramyl peptides, 188
IL-1, 13, 522
murine lupus, 260
IL-10, 497 murine lupus nephritis, 45?
IL-2, 6, 36, 219, 266, 497 mycobacteria, 503
IL-2 receptor, 336 myeloproliferative and myelodysplastic syndromes, 3
IL-3, 266
IL-4, 497 naturally occurring mitochondrial antibodies, 509
IL-6, 106, 522 neoplasia, 56
ileitus, 275 nephropathia epidemica, 13
immune complexes, 88, 394 nephrotoxic antibody, 312
immunization, 223 neutralizing antibodies, 85
immunoconglutinins, 251 neutrophil, 228
immunoelectron microscopy, 319 neutrophil activation, 63
immunoglobulins, 351 neutrophils, 72, 79, 175, 300
immunohistochemistry, 330 NF-«B, 188
immunopathogenesis, 383 nitrate, 326
immunosuppression, 124, 260 nitric oxide, 326
immunotherapy, 357 nitrite, 326
infection-enhancement, 383 NK activity, 181
inflammatory bowel disease, 85 node, 204
integrins, 280 non-T cells, 286
interferon-gamma, 13, 175, 497, 522 nucleosome, 56
interleukin-lx and ~, 312
interleukin-4, 286 oxidative metabolism, 63
interstitial lung disease, 18, 447
intravenous immunoglobulins, 357 P. aeruginosa antigens, 209
paratuberculosis, 503
Langerhans celis, 530 PDGF, 447
laser, 43 peptides, 194
lectins, 517 phospholipids, |
leishmaniasis, 219 pig, 223
lentiviruses, 18 plant mitochondria, 509
LeuCAM, 99 pneumococcus, 199
leucocytes, 99 polycystic ovaries, 401
552 Subject Index
polymerase chain reaction, 147 T cell activation, 36, 170
polymorphism, 517 T cell proliferative responses, 194
polymorphonuclear leucocytes, 280 T cell receptor, 275, 440
primary biliary cirrhosis, 88 T cell responses, 93
primary sclerosing colangitis, 79 T cell subpopulations, 25
priming, 491 T cells, 286, 497
prostaglandin E>, 483 T lymphocyte, 235, 459, 491
Proteinase 3, 409 T lymphocytes, 483
proteinuria, 129 T-cell dependent B cell response, 135
pyruvate dehydrogenase, 509 TCR-yd* lymphocytes, 345
Thl, 497
Th2, 497
quartz, 68
thrombin, 300
thyroid autoimmunity, 363
randomized controlled trials, 357 thyroid peroxidase, 93
reactive oxygen metabolites, 68 time-course, 147
receptor, 161 TNF-a, 447
recombinant autoantigen, 93 toxic antigens, |
reverse transcription, 147 tuberculin-induced delayed-type hypersensitivity, 522
rheumatoid arthritis, 256, 440 tuberculous effusions, 215
rheumatoid factor, 256 tubular basement membrane, 319
tumour necrosis factor, 68, 99, 280
sarcoidosis, 99 Tumour necrosis factor-alpha, 13, 43, 49, 312, 483, 522
SCID mice, 135
SCID mouse, 466, 476 ubiquitin, 453
scleroderma, 447 ulcerative colitis, 79, 271
secretory IgA, 305
serology, 503 V gene usage, 440
serum amyloid A, 293 vaccines, 188
severe combined immunodeficiency, 390 vasculitis, 228
sheep, 204 viral diseases, 13
signal transduction, 161 visna, 204
sIL-2R, 43, 219 visna-maedi virus, 18
SLE, 235, 434 von Willebrand factor antigen, 88
spondylarthropathy, 275
syphilis, 434 xenogeneic transplantation, 135
systemic lupus erythematosus, 56, 106, 135, 245, 251, 422 xenotransplantation, 476